Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
A

ASCO® 2023 Insights: "Development & Validation of an AI-Derived Digital Pathology-Based Biomarker to Predict Benefit of Long-Term ADT With RT in Men With Localized HR-PC Across Multiple Phase 3 Trials"

By Insights from 2023 ASCO® Annual Meeting FEATURING Andrew Armstrong
By Insights from 2023 ASCO® Annual Meeting FEATURING Andrew Armstrong
52 views
June 12, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
GU
11:37
Insights from 2023 ASCO® Annual Meeting

Assessment and Decision Tools for Balancing Survival and Quality of …

Feat. E. Kessler
07:44
Insights from 2023 ASCO® Annual Meeting

Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in…

Feat. J. Graff, A. Sokolova
09:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Prospective Trial of Apalutamide & …

Feat. D. George
09:59
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Determinants of Resistance to Nivo Monoth…

Feat. D. Braun
17:48
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Combination Therapies Come of Age in Kidn…

Feat. D. Braun
03:49
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "HR-QoL Measures in RCC - Patient-Reported…

Feat. C. Decat Bergerot
15:15
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Discussion of LBA4619, Phase 3 THOR Study…

Feat. D. Petrylak
16:14
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/R…

Feat. E. Waller
11:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR -…

Feat. T. Hutson
09:59
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "When to Play the Systemic Therapy Card in…

Feat. K. Runcie
23:16
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients…

Feat. B. McGregor
06:13
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Analysis of Real-World Treatment …

Feat. Y. Zakharia
07:10
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Use of ctDNA to Complement Tumor Tissue H…

Feat. A. Azad
04:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Safety Analyses From the Randomized, Plac…

Feat. A. Azad
13:54
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Key Bladder Cancer/Urothelial Carcinoma Up…

Feat. G. Sonpavde
17:23
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMA-PET Imaging Case Studies and Sequenc…

Feat. P. Tran
16:52
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of Phase 3 PEACE-1 Randomized Tri…

Feat. A. Bossi
09:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabo…

Feat. H. Ebrahimi
07:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Host Immune Signatures Wit…

Feat. E. Saad
05:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Tr…

Feat. T. Flaig
08:59
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Poster Sessions From Dr. Andrew Armstrong in Prostate Can…

Feat. A. Armstrong
07:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Development & Validation of an AI-Der…

Feat. A. Armstrong
09:44
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Safety of Avelumab 1L Maintenan…

Feat. J. Bellmunt
10:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Preliminary Results of Arm B5 of the Phas…

Feat. L. Albiges
19:50
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Adding Clarity to Non-Clear Cell Carcinom…

Feat. M. Schmidinger
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Enfortumab Vedotin +/- Pembro in Pts Who …

Feat. T. Friedlander
07:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 …

Feat. N. Sayegh
11:46
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Te…

Feat. S. Gupta
05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
09:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab f…

Feat. B. McGregor
08:22
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzum…

Feat. S. Tagawa
08:25
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase I Dose-Escalation Results of PSMA-T…

Feat. S. Tagawa
05:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR3 Alterations in Phase III PROOF 302 …

Feat. P. Grivas
09:16
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 Study of Batiraxcept (AVB-S6-5…

Feat. K. Beckermann